Viewing Study NCT06642961


Ignite Creation Date: 2025-12-24 @ 12:36 PM
Ignite Modification Date: 2025-12-28 @ 11:53 PM
Study NCT ID: NCT06642961
Status: RECRUITING
Last Update Posted: 2024-10-15
First Post: 2024-10-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase II Trail Evaluating the Efficacy and Safety of GR1802 Injection in Patients with Moderate to Severe Asthma
Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module